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Smrdb muscle cd3 pmlifer~tioo and iormation of edr~reltular 
matrix we parts 0r tk repair prows after vascular injury. 
Simitar processes occur after eoreitary angioplasty sod, i” ap 
poxlmatcly 33% of wsseb, lead to intilllPl hyperptasi~ aad 
vascular rtstenosts within 6 months after angjc@asty. 1” a r*t 
owdel of battooe catheterimttcm. tbe oroliferativr resomse to 
bpllma injury WPI reduced by 70% nadthe arm of v&&r wall 
covered bv l&e fonoalioe was decrawJ bv 45% in rats keeled 
with Ihe &$&nri~ottv9l1iIg enzyme inhibitor cilpzapril. 
Other antihyprtensive agecnts were much ksr active wben 
lsti for suppre~ia;: of intbnat hyprptrsta after txattmm injntq: 
verapamil 0%. minoxidil4% and hydrab&e 34%. For cilwqril 
al tbe dose of 10 m&g pr day. apqrarimstely 20% greater 
Arteriosclerosis is charasterired by progressive arterial ste- 
nosis of the large muscular arteries. In patients. there lekx 
are composed of smooth muscle cells. extracellular matrix 
fmm these cells, variable amounts of lipid and lesser nom- 
bus of macrophanelmonocvtes and Ivmphocvter (I). lo 
general. the e&es~ identifiable lesion k a.neoikimal accw 
mulation of smoolh muscle cells. often in people with a 
ooroml plasma lipid profile. Thus. the basic pathologic 
features of advanced arteriosclerosis are proliferation of 
smooth muscle cells in the arterial intima and secretion of 
extracellular matrix by these cells. 
An accelerated version of this proliferative process ap- 
pears to lx the underlying cause of bale restenosis in coro- 
nary arteries that have been successfully opened by percu- 
taneoos coronary angiaplasty (2.3). The hallwn angioplasty 
procedure causes endothelial denudation and significant 
tissue damage to both the arteriosclerotic plaque and the 
media of the corooary artery. After the balloon catbeter- 
induced injury. a prominent part of the reparative process is 
the activation of normally quiescent smooth muscle cells to 
proliferate and produce extracellular matrix pmteins. Al- 
though these proliferative processes occur normally to repair 
the w&at &nags after angioplasty. in approximately 36% 
uf pstients. the smooth muscle cell proliferation is excessive 
and leads to new lesion formation and clinically symptomatic 
resteaosis. 
Inhibitors of Smooth Muscle 
Cell Proliferation 
Angioteosiwe”averliag enzyme inhibitors. The develop 
meat of swcilic therapy to prevent restenosis has been 
difficult. in part be&~ the &chaoisms that control the 
proliferative response to vascular injury are oat uoderstood. 
Fortunately. similar proliferative lesions can be studied in 
animal models (4.5). I” the rat carotid artery. these lesions 
are composed predomioantly of proliferatios smooth muscle 
cells in the intima sod are induced by vigorous ballwn 
catheterization. essentially similar to angioplasty. Thus. the 
factors that promote smwth muscle cell migration and 
proliferation in the vascular wall can be studied and the 
regulvrory processes manipulared. Recently. we (6) reported 
that the an~otenrinconverting enzyme inhibitor cikuapril 
markedly suppressed the formation of oeointimal lesions 
after balloon catheterization in the rat carotid artery. An- 
giatensin-converting enzyme inhibitors are relatively spz- 
cilic for the converting enzyme and their pmved aotihyper- 
tensive effects are believed to be due to the block of 
production of the potent vasoco”stricror peptide angiotensin 
II (7). However. the mechanisms underlying the growth- 
promoting activities of angiutensin II are less well under- 
stood and anaiotcnsin-convening enzyme inhibitors have 
other properties. including inhibition of other enzymes po- 
tentially involved in the proliferative x~rmnsc (8.91. In 
addition, angiotensiwconverting enzyme functions as one of 
the major metabolic enzymes to degrade bradykinin, thus 
raising the question whether some of the suppression of 
neointimd corm&on is mediated through the increase in 
bradykinin lsvelr after angiotensin-convening enzyme inhi- 
bition. 
Heparin. Heparin has also been reported IS, to inhibit 
neoiatimal formation in the rat carotid artery after balloon 
catheterizatmtt. However, attempts to use heparin in clinical 
trials to prcvcnt restenosis after angioplasty have been 
severely limited because of problems with long-term admin- 
istration and complications of anticoagulant therapy. Hep- 
arin is a chemically heterogeneous mixture of complex 
glycosaminoglycans composed of repeating disaccharide 
units. Infusion experiments in viva and cell culture assays in 
vitro have demonstrated that heparin inhibits smooth muscle 
cell proliferation and migration (2,. Cast&t et al. (I01 
reported that heparin binds to the surface of the smooth 
muscle cell and is mtemalired. Heparin is a highly charged 
sulfated molecule, and it has apparent interactions with 
several growth factors and extracellular matrix proteins (I I ). 
Whether any of these interactions mediate the antiprolifera- 
tive effects of heparin remains to be clarified. 
In the pieseat studies, we compared these two inhibitors 
of smooth muscle cell proliferarion in viva. The resutts 
indicate that an%iotenrin-convening enzyme inhibitors may 
have therapeutic usefulness in inhibiting the vascular re- 
sponse to injury. heparin and angiotensin-coaverting en- 
zyme inhibitors suppress proliferation through ditTerent 
mechanisms and the use of rational pharmacologic combina- 
tions may be necessary to achieve optimal control of the 
progressive arterial stenosis seen after coronary angioplasty 
and in arterioscleror~s. 
Methods 
Arterial ittjury model. Endothelial denudation and injury 
to the vascular wall were achieved in the left common 
carotid artery in 4 month old male normotensive rms (400 to 
5W g, as described elsewhere (4.6,. In brief. rats were 
anesthetized with use of intraperitoneal administration of 
sodium pentobarbital (Vetanarcol. 40 &kg). The distal left 
commmt carotid artery and the region ofthe bifurcation were 
exposed. A Fogarty ZF balloon embolectomy catheter (Ed- 
wards Laboratories, was introduced through the external 
carorld anery and advanced into the thoracic aorta. The 
balloon was inamed and the catheter stowtv withdrawn with 
a twisting motion until the balloon was at the bifurcation. 
The balloon was inflated sufficiently (filling volume O.oOb’ to 
0.012 ml) to distend the common carotid artery and resist 
withdrawal of the catheter. After three repetitions of this 
procedure, the endotbelium was removed completely and 
the superficial layers of the media sustained mild to moder- 
ate cellular injury. After removal of the catheter, the exter- 
nal carotid artery was ligated and the wound closed. 
During the same period of anesthesia, some of the rats 
received implantation of 14 day 2 ml mini-osmotic pumps 
(Alza Corporation,. These pumps were incubated overnight 
at 37°C in physiologic solution to inhiate osmotic pumping 
action so that the compounds were administered reliably 
without delay after implantation of the pumps into the 
subcutaneous tissue of the back and insertion of the outflow 
catheter into the internal jugular vein. 
Carotid artery proporation. After I4 days, the rats were 
anesthetized and perfusion fixed as described elsewhere 
(12). with the modification that 2.5% glutaraldehyde and a 
90 mm He. oerfusion messure were used. The vascular 
system was &d with’ IO ml of phosphate-buffered saline 
solution before infusion of fixative solotion. Both carotid 
arteries were isolated from adherent tissue. placed in 2.5% 
ghttaraldehyde in 0. I M cacodylate buffer for farther fixation 
and embedded in Epott 812. Semithin sections (I ,umLm) were 
stained with toluidine blue and basic fuchsin and processed 
for morphometric evaluation. The carotid artery was divided 
into segments for sectioning and measuring the parameters 
outlined in Figure I. 
Drugs administered. In the experiments discussed in this 
repon. the following compounds were administered: cilaza- 
pril at the doses indicated (typically 10 mgtkg per day mixed 
with normal food); captopril (IO!3 mg/kg per day mixed with 
normal food,; verapamil (IO0 m@g per day orally): hydrala- 
zinc (8 mpikg per day in drinking water,: minoxidil(5 mgikg 
per day mixed with normal food): aspirin (0.3 mg/kg par day 
or 3 “g/kg per day) and heparin (0.3 mg/kg per h Liquemin, 
F. Hoffmann-LaRoche Ltd. by infusion from aa Alzet os- 
motic minipump). Except for aspirin attd heparin, these 
doses were selected from preliminary experiments (data not 
shown) and they reduced blood pressure by approximately 
20% in the normotensive rats used in there studies. 
RC5UltS 
Vascular response to ballwn catheter-induced injury (Fig. 
2). This vascular reswnse is understood most fully for the 
rat carotid artery and.rabbit iliac artery. but the e&t8 after 
angioplasly in human coronary arteries are believed to be 
essentially similar. except that they develop over a some. 
what longer time coarse. 
E&t of cilazapril and captoprll on the proliferative R- 
swase to vascuIar injury. The angiotensibconvertiag ea- 
Lyme inhibitor cilazapril markedly suppressed the prolifera- 
live response to balloon catheter-induced vascular injury in 
the rat carotid artery. The results for cilazapril (IO &kg-per 
day mixed with normal food from 6 days before balloon 
catheterization until the time of sacrifice for analysis 14 days 
after catheterization) are shown in Ftgure 3. Roth the 
aat~ttnt of neointima and the extent of arterial wall covered 
by lesion formation were significantly reduced. Histologi- 
Figure 1. Schematic diagram of morphometric variables evaluated 
using 8 DlASYS morphometry s slem (Dalalab. Heinz Meyer) for 
sections of each carotid artery: area of neoinrima = cross-rec,ionsl 
area (in e’) of the newly formed intima Wointimal: neoimimai 
media = the ratio of the cmwxctional area of the newly formed 
intima tneointima) to the cmwzeclionaI arca of the media of the 
injured carotid artery: and coverage of arterial wall by neoinlima = 
the percent length of the internal elastic lamina covered by neoin- 
tima.The neointimaimediaratioisusedto nolmalizethedataforthe 
variation among individual carotid arteries. In the experiment5 
describzdintbis stlidy. tbecmsssectianal areaoftbe mediauasnot 
a&ted by any of the treatment schedules. 
tally, it appeared that there were comparable decreases in all 
components ofthe neointima. For cilazapril. the reduction of 
neointima was dose dependent up to the highest dose tested 
(30 m&j. For another angiotensin-converting enzyme in- 
hibitor, captopril, only one dose llO0 mglkg per day mixed 
with food) war tented and the results were similar to those 
with cilazapril (IO mglkg per day) for decreasing blood 
pressure and suppressing neointimal formation ;dala not 
shown). 
To assess whether the suppression of neointimal forma- 
tion was uniform thmughout the region of balloon catheter- 
induced injury. we analyzed multiple cross sections from the 
aorta to the bifurcation of the carotid artery. Results shown 
in Figure 4 demonstrate that the response to the balloon 
injury in this animal model is consistent over the injured 
arterial segment and that administrarion of an angiolensin- 
convening enzyme inhibitor suppresses the proliferative 
response in each segment. 
Because many angioplasty procedures are performed on 
the same day as diagnostic arteriography. it was important o 
test in the rat model whether prior admmisrration of the 
angiotensin.converting enzyme inhibitor was necewry to 
suppress the prolifcrdtive rerponse to vascular i!jury. The 
results in Figure 5 indicate that the rupprersion of neointimal 
formation was similar whether treatment started just before 
(6) or 2 days after balloon catheterization 0. However, the 
amount of neointima was consistently about 20% less in rats 
treated from 6 days before ba!l& injury (A). Treatment 
schedules starling at days 2 to 5 before balloon injury were 
not tested. 
Effect of ofk vssodilstors. Angiotensin-converting en- 
zyme inhibitors are commonly used to lower blood pressure 
Qure3. lnlubition of neointimat formation by adminirtntionofthe 
angiotenrinsonvcning enzyme inhibitor cilazaprit Cl in the rat 
model of vascular injury by balloon cathelerizdion. In this experi- 
men,. cdazqm, wasadminirtercd from6 days before to Mdaysancr 
balloon csrhcrerization. Tk dorc of cita2aprit (10 m&g per day 
nuxed wh food) was selected so that plasma angiotensin- 
converting enzyme activity was inhibited >9G% and thus bloc4 
pressure was lowered by approximately 2wc in there nomwtensive 
ratr.Wenum~ri.~~IIbYi.thenumberafanimatrineacheoup. 
Results are erprersed as mean values ? SEM: p C O.WI compared 
wilh the panllel pkcbo (PI) group ISadcnl‘r lwwailed I lest). 
El. = i”lemal ebrric hmina. 
Figure 4. Neoinoma, formation in different sections of the rat 
carotid artery after balloon calheleriration in placebo-treated ani- 
mals copon bars) and cilarapril-lrealed animals WI mgikg per day, 
from 6 day, below to 14 days after balloon iojury (hatchrd bars,. 
Seaions are numbered from the bifurcaiion of,he carotid artery. 1. 
to the arch of the aona. 6. Results are exsressed as mean values t 
SEM: p < osm,, except section 2: p c l&MS. 
and have significant effects on vascular tone. Because i, was 
possible thai these effects mediale the sumxession ofneoinl- 
&I formation by angiotensin-convenin &yme inhibitors. 
we compared the elTects of several other vasoaclive com- 
pounds on neointimal formation (Fig. 6). The calcium anfag- 
onist verapamil had no effect on either neointimal area or 
extent of lesion formation. Two direct-acting vasodilaors 
wore also tened. Minoxidil had no significant effect and 
hydralazine moderately suppressed neointimal formation. 
Figure 5. Effecis of diKerent treatment schedules for cilazapril on 
formalion of neoimima after vascular injury by balloon cathaeriza- 
lion. Cross-seclional area of neoinlima was measured in sections of 
the middle fifth of the left carotid arwry prepared 14 days after 
cathelerizalion. Noninjured normal an&s had RO neointimal for- 
mation. Treatment schedules were cilazapril 00 mglkg per day) as 
follows: A = from 6 days before to 14 days after balloon injury: B = 
from the day of Injury IO 14 days after ballwn injury: C = from 2 10 
14 days afler injury: D = from 6 days before 10 2 days after iojury. 
For groups A. B and C Ihe suppression of neointima was highly 
signihcanl Ip < 0.0011 compaxd wilh the pardUe, placebo group 
IStudent’s Wo-t&d I test,. 
PI MI Pi w PI Ml” A v.r 
Figure 6. Inhibition o: neamtimal formation by adnkIis,ralion of 
calciom channel anlr,,uds,s or vasodilaling agems in the rat model 
of vaxolar injury by balloon catheterization. The tested compaunfs 
were administered from 6 days before to 14 days after balloon 
cathelerizalion. The doses were selected so that blood pressure was 
lowered by approximately 28% in each test group. Results are 
expressed as mean values + SEM; p < O.WI for cilazapri, S3,). p < 
II.05 for hydralanine (Hydl and p = NS for minoxidil (Min) or 
verapamil Wer,. PI = placebo. 
E&l of aspirin. The effect of aspirin on neointimal 
formation was tested during both independent administra- 
tion and concurrent administration wilh cilazapril. At either 
low or high doses. there was no effect on the proliferative 
response to balloon injury 2nd administralion of aspirin did 
not alter the neointimal suppression caused by cilazapril 
(Fig. 7). 
E6ecl of heparin. Heparin infusion inhibited the migra- 
lion and proliferation of vascular smooth muscle cells in this 
rat model as previously reported (5). The admininiralion of 
cilazapril (IO mgikg per day) from the day of balloon calhe- 
terization suppressed neointimal formation approximately as 
effectively as heparin alone. but much greater suppression of 
neointimal formation resulted when heparin and cilazapril 
Figure 7. Aspinn (ASA) does not contribute 10 the inhibition of 
neoinlimal formation by adminislralion of angiotcnsin-convening 
enzyme inhibitors in the rat mcdel of wcular iqjury by balloon 
calheterization. In lhis expcrimenr. cilazapril 01) was adminislcred 
from 6 days before to 14 days after balloon cathelerization. Aspirin, 
ao irreversible inhibitor of platelelet cyclooxygenase. was tested at 
low (0.1 @kg per day) and at high 13 &k6 per day) doses. ‘p < 
O.W, compared with con~ur~erd placebo W’O group. 
Figure 8. Inhibition of neointimal form&n by cilazapril IOU and 
he&n (HepI in the rat model of vascular mjury by balloon 
catheterization. I  this expaiment. the angiotensinxonvening e - 
zyme inhibitor cilazapril WBE administered in a suboptimal regimen 
from I day betore 10 14 days after ballmn eatberedzarion. Heparin 
IO.3 mgikg per h. Liquemin. F. HotTmarm-La R ebe) was adminis- 
tered intravenously for 14 days through a catheter in the internal 
jugular vein from an Alzct osmotic minipump implanted rubcutane- 
ously at the Lime of Mlwn calheterizatiun. All animals were 
analysed at I4 days. PI = placebo. p < 0.001 compared with the 
parallel placebo group. 
were administered together (Fig. 8). Blood pressure was not 
lowered by heparin alone nor was the blood pressure- 
lowering effect ofcilazapril enhanced by coadministration of 
heparin. 
Discussion 
hIeehanismdsuppw&n of neaintimal proliferation. An- 
aiotensin-converting enzyme inhibitors such as cilazapril sup 
&es balloon catheter-induced neointimal format&. moit 
likelv bv hlwkina the conversion ofangiotensin I to the active 
p&de. angiote&in II. thus prevent& the stimulation by 
angioiensin II of vascular snmoth muscle cell pmlifemtion and 
matrix pro&n synthesis. In this model of balloon injury in the 
tat carotid artery, the vascular response to injury is tr&ered 
throughout he ballooned segment of artery, from the aortic 
arch to the bircation of the carotid artery. and the formation 
of neointima oars concentrically. Treatment with the an- 
giotensinamwting enzyme inhibitor cilazapril redwed the 
amount of neointima formed by day I4 in all segments com- 
pared with that in placebo-treated animals. In addition. the 
extent ofarterial wall covered by lesion formation was reduced 
significantly. 
Several conclusions were suggested by the observations 
that cilazapril suppressed neointimal formation almost as 
effectively when treatment was started 2 days after balloon 
injury as when it was started 6 days before catheterization 
and that continuous treatment was necessary. First. it was 
unlikely that mechanical effects ofvasorelaxation at the time 
of balloon catheterization were the primary mechanism 
involved in modulating the vascular rerponne to injury. The 
influence of blood pressure lowering and vasorelaxation on 
neointimal formation was assessed further by comparison 01 
the effects of angiatensin-convening enzyme inhibitors and 
those of other antibyperten+e agents that do not primarily 
alter aneioten&convertine enzvme xtivitv. The sum~res- 
sion of &mime: format& in ;ats :rc?ted with the’brher 
antihypertcnsive agents varied from no effect to 34% inhibi- 
tion. but was much less than the suppression of wointima 
seen in rats treated wirh angioteosin-convening enzyme 
inhibitors, despite similar lowering of biood pressure in the 
different groups. The lack of inhibitory effect after treatment 
with the calcium antagonist verapamil is consistent with 
clinical experience in studies (2.13) using calcium channel 
antagonists to prevent rcstenosis after coronary angioplasty. 
However. in view of fix in vitro evidence that some calcium 
channel antagonisrs can inhibir the proliferatioo of culiurcd 
vascular smocth muscle cells (2.14). it is possible that more 
recently developed calcium channel antagonists could prove 
useful in inhibiting neointimal formation. prhaps in con- 
junction with angiotcnsin-converting enzyme inhibitors. 
Potential of cc&&d thmpg. Our findings demonstrate 
the potentiil of combining agents with different mechanisms 
of action to block the neointimal respmse to balloon cathe- 
ter-induced x~ular injury and provide insight into the role 
of angiotensin-convening enzymes in the vascular response 
to injury. The action ofcilazapril is to inhibit specifically the 
angiotensin-converting enzyme. Our experiments with vas- 
cular smooth mwle cells in cell culture show that unlike 
heparin. cilazapril did not affect these cells directly (Poweli 
et al.. unpublishedobservations). Proliferation stimulated by 
serum &s not altered by cilazapril or its metabolite cilaza- 
prilare. Thus. it is most likely that the inhibitory effect of 
cilazapril is mediated through the consequence of inhibition 
ofthe convertingenzyme. Hepxin. in contrast. has no effect 
on the enzyme and directly inhibits smooth muscle cell 
pmlifcration in cell culture at concentrations that have been 
shown to inhibit neointimal formation in viva. By inhibiting 
the angiotensin-converting enzyme with cilazapril and 
smooth muscle cell proliferation with heparin. the formation 
of neointima after balloon injury WBP inhibited by at least 
two mechanisms. resulting in SW6 suppression. 
The oplimal trealmml regimen. In these experimenls. we 
did not define the optimal @men for administration of 
cikaapril and heparin. From irevious studies using each 
agent individually and from the evidence presented here for 
different mechanisms of inhibition of smooth muscle cell 
proliferation. we expect that an optimal regimen would be 
administration of cilazapril throughout. to maintain continu- 
ous inhibition of converting enzyme. and heparin adminis- 
tration during the acute phase of the vascular response to 
injury. In the nit. administration of heparin intravenously 
from I2 to 48 h after ballaan catheterization inhibited neoint- 
imal formation as effectively as infusion of heparin for the 
full 2 weeks (IS). However. similar studies have not been 
reported for other species and. especially in humans. much 
less is understood about the proliferative response to vascu- 
lx injury, such es that after coronary angioplasty. These 
studies are important because compounds such as heparin 
have several potentially important side effects when admin- 
istered for lone oeriods. includine osteooorosis and stimula- 
tion of produ&n of the extrace~ular matrix that forms part 
ofthe neointima. In the rat balloon model, Clowes et al. IIS) 
reported that at 4 weeks, animals treated with heparin had 
increased extracellular matrix and the suppression of neoint- 
imal formation at 4 weeks WBE much less significant. 
Whether similar effects on matrix protein production occur 
in other animal species and humans remains to be deter- 
mined. 
Cultured rat an&l smooth muscle cells pmduce low levels 
ofplatelet-derived growth factor-like miQwic activity. When 
smwth muscle cells from the neoinlima of a balloon-iriiured 
attery are placed in culture. these cells produce platelet- 
derived growth factor-like substances (16). Becxise angioten- 
sin II stimulates wcduction of platelet-de&d growth factor- 
likeactivity in &red smooth ~usc!: cells(l6)~itis attractive 
to hypothesize that the prcdurtion of angiotensin II in the 
damaged arterial wall is important in the activation of smooth 
muscle cells to synthesize mitogens and proliferate. However. 
the control of mitogen expression in vivs and the mle of 
angiofensin-wnverting enzymes in the regulation of smooth 
muscle cells in the corcmary anay remain important consider- 
ations. Nonetheless, our data demonstrate the advantages of a 
combination of phamtacologic apprcaches with agents having 
diierent mechanhms of action to block smooth muscle cell 
proliferation and neointimal formation after vascular injury. 
